Your Patients Can't Find Prasugrel — Here's How You Can Help

As a prescriber, few things are more frustrating than choosing the right medication for your patient — only to learn they can't fill it. Prasugrel (Effient) is one of those medications that can fall through the cracks at the pharmacy level. It's a potent, evidence-based P2Y12 inhibitor, but its niche indication means many retail pharmacies don't stock it consistently.

This guide provides a practical framework for helping your patients secure their Prasugrel prescriptions without treatment interruption.

Current Availability Landscape

As of 2026, Prasugrel is not in formal shortage, but patients frequently encounter stockouts at chain pharmacies. The root causes are well-understood:

• Low retail demand: Prasugrel's indication is limited to post-PCI ACS patients, a much smaller population than the broad cardiovascular market that Clopidogrel serves.
• Limited generic manufacturers: Fewer production sources mean less supply chain resilience.
• Distributor allocation: Wholesalers may cap orders of low-volume medications, limiting what pharmacies can obtain.
• Pharmacy stocking algorithms: Chain pharmacies use automated inventory systems that may deprioritize low-turnover drugs like Prasugrel.

Why Patients Can't Find It

It's important to understand the patient experience. When a patient is discharged post-PCI with a Prasugrel prescription, they typically go to their regular pharmacy — often a large chain. If that pharmacy doesn't stock Prasugrel, the patient faces:

• A time-consuming search calling multiple pharmacies
• Anxiety about going without a critical medication
• Potential financial barriers if they find it at an out-of-network pharmacy
• Confusion about whether they should just take aspirin alone (they shouldn't)

This is where your practice can make a significant difference.

What Providers Can Do: 5 Actionable Steps

Step 1: Verify Availability Before Discharge

The simplest intervention is confirming that your patient's pharmacy has Prasugrel in stock before they leave the hospital. This can be done by:

• Having your discharge coordinator call the patient's preferred pharmacy
• If unavailable, arranging a fill at the hospital outpatient pharmacy
• Providing the patient with a list of nearby pharmacies known to carry Prasugrel

This one step can prevent the majority of access issues.

Step 2: Build a Pharmacy Network

Identify 3-5 pharmacies in your area that reliably stock Prasugrel. This typically includes:

• Hospital outpatient pharmacies — These almost always carry cardiac medications
• Independent pharmacies near your practice — They may already serve your patient population
• Specialty cardiovascular pharmacies — Some pharmacies specialize in cardiac and anticoagulation medications

Maintain this list and share it with your nursing and discharge planning staff. Update it quarterly as availability changes.

Step 3: Use Medfinder for Real-Time Stock Checking

Medfinder for Providers lets your staff check which pharmacies near your patient currently have Prasugrel in stock. This is faster and more reliable than phone calls and can be done at the point of prescribing.

Consider integrating a Medfinder check into your post-PCI discharge workflow. When your nurse or PA writes the discharge medication list, they can verify Prasugrel availability in real time and direct the patient accordingly.

Step 4: Maintain Bridge Supplies

Keep a small stock of Prasugrel samples or starter packs in your office. When a patient encounters a fill delay, you can provide a bridge supply to prevent any gap in antiplatelet therapy.

This is particularly critical in the first 30 days post-stent, when the risk of stent thrombosis from DAPT interruption is highest.

Step 5: Streamline Prior Authorization

Some insurers require prior authorization for Prasugrel, particularly for the brand-name Effient. Prepare your practice to handle PAs efficiently:

• Pre-populate PA forms with standard ACS/PCI documentation
• Include the specific clinical rationale (e.g., "patient with STEMI status post DES placement, DAPT with Prasugrel and aspirin per ACC/AHA guidelines")
• Note if the patient is a CYP2C19 poor metabolizer or has failed Clopidogrel
• If step therapy is required, document the clinical basis for bypassing Clopidogrel trial

Alternative Medications to Consider

When Prasugrel truly cannot be obtained and the clinical situation demands immediate action:

• Ticagrelor (Brilinta): The closest alternative in terms of antiplatelet potency. Reversible binding, no CYP2C19 dependence, but requires twice-daily dosing. Generic now available at approximately $30-$80/month with coupons. Notable for dyspnea side effect.
• Clopidogrel (Plavix): Widely available and affordable ($4-$15/month), but lower potency and subject to CYP2C19 genetic variability. Best for lower-risk patients. Consider platelet function testing if switching from Prasugrel.
• Cangrelor (Kengreal): IV-only, hospital-use P2Y12 inhibitor. Useful as a bridge during procedures but not a substitute for outpatient oral therapy.

For patient education on alternatives, direct them to: Alternatives to Prasugrel.

Workflow Tips for Your Practice

Here are additional workflow optimizations to reduce Prasugrel access issues:

• E-prescribe to confirmed pharmacies: When sending the prescription electronically, route it to a pharmacy you've confirmed has stock — not just the patient's default pharmacy.
• 90-day prescriptions: Where insurance allows, prescribe 90-day supplies to reduce refill frequency and minimize the number of times patients need to locate stock.
• Refill reminders: Encourage patients to refill with at least one week of supply remaining. This provides buffer time if the pharmacy needs to order.
• Educate patients at discharge: Provide written information explaining that Prasugrel is a niche medication, not all pharmacies carry it, and where to look if their pharmacy is out. Include medfinder.com as a resource.
• Document medication access issues: If a patient reports persistent Prasugrel access problems, document this in their chart. It can support PA appeals and alternative medication justifications.

Final Thoughts

Prasugrel access challenges are a workflow problem, not a clinical one. The medication is available — it's just not always where your patients expect to find it. By building availability verification into your discharge process, maintaining a pharmacy network, and using tools like Medfinder, you can significantly reduce treatment gaps.

For the broader clinical and supply chain context, see our provider briefing: Prasugrel shortage — what providers need to know in 2026.

For cost-saving strategies to share with patients, visit: How to help patients save money on Prasugrel.